HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 23 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $563,000 | -82.4% | 404,963 | -31.4% | 0.48% | -77.6% |
| Q4 2021 | $3,198,000 | -15.1% | 590,000 | -10.6% | 2.14% | -22.6% |
| Q3 2021 | $3,769,000 | +21.5% | 660,000 | +23.6% | 2.77% | +31.8% |
| Q2 2021 | $3,103,000 | +31.9% | 534,000 | +24.2% | 2.10% | +20.3% |
| Q1 2021 | $2,352,000 | +28.7% | 430,000 | +12.7% | 1.74% | +11.9% |
| Q4 2020 | $1,828,000 | – | 381,713 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighMark Wealth Management LLC | 6,966 | $7,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 57,454 | $59,000 | 0.00% |
| Virtu Financial LLC | 13,127 | $14,000 | 0.00% |
| UBS Group AG | 26 | $0 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 60 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 13 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 50 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 47,178 | $48,000 | 0.00% |
| STATE STREET CORP | 14,455 | $15,000 | 0.00% |